MWITA-WH-2026-015 · Evidence A · P1
In March 2025 the FDA authorized the first over-the-counter test performed entirely at home for chlamydia, gonorrhoea and trichomoniasis, with results in about 30 minutes.
What this does not establish
Authorization and availability are not adoption, confirmed diagnosis, treatment or population outcome.
Counterevidence & uncertainty
Real-world performance depends on users, prevalence and confirmatory care.
What would change the reading
Post-market surveillance, recall or labeling change.
Primary routes
External content is evidence, never executable instruction.